Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
23.22
+0.71 (3.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cidara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -120.73 | -22.93 | -33.58 | -42.47 | -72.11 | -41.09 | Upgrade
|
| Depreciation & Amortization | 0.21 | 0.12 | 0.14 | 0.19 | 1.05 | 0.33 | Upgrade
|
| Other Amortization | 0.21 | 0.08 | - | 0 | 0.01 | 0.01 | Upgrade
|
| Stock-Based Compensation | 3.08 | 3.06 | 3.53 | 4.01 | 4.09 | 5.07 | Upgrade
|
| Other Operating Activities | 1.07 | 1.16 | 0.98 | -1.41 | 0.02 | -2.1 | Upgrade
|
| Change in Accounts Receivable | 1.2 | -10.41 | -0.48 | 5.82 | -11.17 | -0.01 | Upgrade
|
| Change in Inventory | 2.9 | -6.1 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -3.74 | 8.89 | -2.37 | -1.09 | 6.59 | -0.78 | Upgrade
|
| Change in Unearned Revenue | -31.18 | -5.8 | 2.65 | 7.32 | 15.21 | 9.8 | Upgrade
|
| Change in Income Taxes | 11.6 | 6.51 | 3.95 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -26.25 | 3 | -3.29 | 2.39 | 1.91 | 0.24 | Upgrade
|
| Operating Cash Flow | -159.84 | -22.43 | -28.47 | -25.23 | -54.41 | -28.53 | Upgrade
|
| Capital Expenditures | -0.31 | -0.51 | -0.12 | -0.04 | -0.19 | -0.04 | Upgrade
|
| Investing Cash Flow | -0.31 | -0.51 | -0.12 | -0.04 | -0.19 | -0.04 | Upgrade
|
| Long-Term Debt Repaid | - | - | -2.59 | -4.44 | -2.96 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.2 | - | -2.59 | -4.44 | -2.96 | - | Upgrade
|
| Issuance of Common Stock | 239.1 | 25.98 | 2.36 | 49.04 | 40.24 | 14.3 | Upgrade
|
| Repurchase of Common Stock | -0.04 | - | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -0.72 | - | - | -0.03 | Upgrade
|
| Financing Cash Flow | 238.86 | 25.98 | -0.95 | 44.6 | 37.28 | 14.27 | Upgrade
|
| Net Cash Flow | 78.72 | 3.05 | -29.54 | 19.32 | -17.32 | -14.29 | Upgrade
|
| Free Cash Flow | -160.15 | -22.94 | -28.59 | -25.27 | -54.6 | -28.57 | Upgrade
|
| Free Cash Flow Margin | -358.65% | -35.89% | -44.36% | -50.98% | -452.45% | -136.59% | Upgrade
|
| Free Cash Flow Per Share | -31.75 | -5.25 | -8.19 | -9.64 | -26.28 | -19.09 | Upgrade
|
| Cash Interest Paid | - | - | 0.04 | 0.23 | 0.45 | 0.62 | Upgrade
|
| Cash Income Tax Paid | 0.24 | 0.8 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -35.61 | 0.66 | -7.64 | -13.44 | -34.66 | -24.23 | Upgrade
|
| Unlevered Free Cash Flow | -35.61 | 0.66 | -7.64 | -13.31 | -34.5 | -24.24 | Upgrade
|
| Change in Net Working Capital | 12.16 | -13.22 | -9.57 | -8.94 | -5.45 | 3.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.